Second, the majority studies included implement the 22C3 pharmDx assay to test the PD-L1 TPS, which is defined based on the proportion of tumor cells in membranous PD-L1 staining.38 PD-L1 positivity refer to a tumour proportion score of 1% or higher. Here, CD274 is linked to neoplasm.